Heterogeneity in Hepatitis B Virus (HBV) Seroprevalence Estimates from U.S. Adult Incarcerated Populations

Annals of Epidemiology

Volumn 19, Issue 9, 2009, Pages 647-650

  Harzke, Amy J ^a   Goodman, Karen J ^c   Mullen, Patricia D ^b   Baillargeon, Jacques ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Hepatitis; Incarceration; Meta Analysis; Prison; Prisoners

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M;

ARTICLE; DEMOGRAPHY; GENETIC HETEROGENEITY; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; UNITED STATES;

ADULT; DATABASES, BIBLIOGRAPHIC; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; PRISONERS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 67949091243     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.04.001     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention. Disease burden from viral hepatitis A, B, and C in the United States. 2002. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/disease_burden2004.pdf. Accessed October 1, 2004.
2. Margolis H.S., Coleman P.J., Brown R.E., Mast E.E., Sheingold S.H., and Arevalo J.A. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 274 (1995) 1201-1208
3. McQuillan G.M., Coleman P.J., Kruszon-Moran, Moyer L.A., Lambert S.B., and Margolis H.S. Prevalence of hepatitis B virus infection in the United Status: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 89 (1999) 14-18
4. Centers for Disease Control and Prevention. Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 39 RR-2 (1990) 1-26
5. Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep 52 RR-1 (2003) 1-44
6. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Part 1: Immunization of Infants, Children, and Adolescents. MMWR Recomm Rep 54 RR-16 (2005) 1-39
7. Centers for Disease Control and Prevention. Hepatitis Surveillance Report No. 60 (2005), US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA)
8. Koplan J.P., Walker J.A., Bryan J.A., and Berquist K.R. Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas. J Infect Dis 137 (1978) 505-506
9. Kibby T., Devine J., and Love C. Prevalence of hepatitis B among men admitted to a federal prison. N Engl J Med 306 (1982) 175
10. Bader T. Hepatitis B carriers in the prison population. N Engl J Med 308 (1983) 281
11. Kaufman M.L., Faiver K.L., and Harness J.K. Hepatitis B markers among Michigan prisoners. Ann Intern Med 98 (1983) 558
12. Decker M.D., Vaughn W.K., Brodie J.S., Hutcheson Jr. R.H., and Schaffner W. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis 150 (1984) 450-459
13. Anda R.F., Perlman S.B., D'Alessio D.J., Davis J.P., and Dodson V.N. Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am J Public Health 75 (1985) 1182-1185
14. Brewer F. Hepatitis B-Similarity of risk among populations. J Pris Jail Health 5 (1985) 102-107
15. Hull H.F., Lyons L.H., Mann J.M., Hadler S.C., Steece R., and Skeels M.R. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health 75 (1985) 1213-1214
16. Bader T., Kibby T., Mueller M., Love C., Khayrallah M., and Ham R. Hepatitis-B in United States prisoners. J Med Virol 21 (1987) A4-A4
17. Tucker R.M., Gaffey M.J., Fisch M.J., Kaiser D.L., Guerrant R.L., and Normansell D.E. Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia state prisoners. Clin Ther 9 (1987) 622-628
18. Andrus J.K., Fleming D.W., Knox C., McAlister R.O., Skeels M.R., Conrad R.E., et al. HIV testing in prisoners: is mandatory testing mandatory?. Am J Public Health 79 (1989) 840-842
19. Barry M.A., Gleavy D., Herd K., Schwingl P.J., and Werner B.G. Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction. Am J Public Health 80 (1990) 471-473
20. Smith P.F., Mikl J., Truman B.I., Lessner L., Lehman J.S., Stevens R.W., et al. HIV infection among women entering the New York state correctional system. Am J Public Health 81 Suppl (1991) 35-40
21. Minshall M.E., Dickinson D.J., and Fleissner M.L. Prevalence of syphilis, hepatitis B virus (HBV), and human immunodeficiency virus (HIV) infection in new arrestees at the Lake County Jail, Crown Point, Indiana. J Pris Jail Health 12 (1993) 135-155
22. Ruiz JD, Mikanda J. Seroprevalence of HIV, hepatitis B, hepatitis C, and risk behaviors among inmates entering the California correctional system. Sacramento, California: Department of Health Services; 1996. Available at: http://www.dhs.ca.gov/ps/ooa/Reports/PDF/Corrections99.pdf. Accessed August 1, 2004.
23. Ruiz JD, Chang JS, Bernstein K, Chow JM, Bolan G, Pettifor A, Parikh-Patel A, Moliter F. Prevalence of HIV infection, sexually transmitted diseases, hepatitis, and risk behaviors among inmates entering prison at the California Department of Corrections; 1999. Sacramento: Department of Health Services; 2001. Available at: http://www.dhs.ca.gov/ps/ooa/Reports/PDF/1996SeroofHIVHepBHepCandRiskAmongInmates.pdf. Accessed August 1, 2004.
24. Macalino GE, Rich JD, Sandford-Colby S, Salas CM, Vlahov D. Intake prevalence and intraprison incidence of HIV, hepatitis B (HBV), and hepatitis C (HCV) among sentenced inmates in Rhode Island, USA. International Conference on AIDS; Abstract 9208; July 7-12, 2002; Barcelona, Spain.
25. Centers for Disease Control and Prevention. Hepatitis B vaccination of inmates in correctional facilities-Texas, 2000-2002. MMWR Morb Mortal Wkly Rep 53 (2004) 681-683
26. Centers for Disease Control and Prevention. Transmission of hepatitis B virus in correctional facilities-Georgia, January 1999-June 2002. MMWR Morb Mortal Wkly Rep 53 (2004) 678-681
27. Macalino G.E., Vlahov D., Sanford-Colby S., Patel S., Sabin K., Salas C., et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 94 (2004) 1218-1223
28. Solomon L., Flynn C., Muck K., and Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health 81 (2004) 25-37
29. Khan A.J., Simard E.P., Bower W.A., Wurtzel H.L., Khristova M., Wagner K.D., et al. Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility. Am J Public Health 95 (2005) 1793-1799
30. Macalino G.E., Vlahov D., Dickinson B.P., Schwartzapfel B., and Rich J.D. Community incidence of hepatitis B and C among reincarcerated women. Clin Infect Dis 41 (2005) 998-1002
31. Hammett T.M., Harmon M.P., and Rhodes W. The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. Am J Public Health 92 (2002) 1789-1794
32. Harrison P.M., and Beck A.J. Prisoners in 2002. Bur Justice Stat Bull. 2003. NCJ 48 (2002) 1-14. Available at: http://www.ojp.usdoj.gov/bjs/pubalp@.htm#P Accessed October 15, 2004
33. Harrison PM, Karberg JC. Prison and jail inmates at midyear 2003. Bur Justice Stat Bull. 2004;NCJ 203947:1-14. Available at: http://www.ojp.usdoj.gov/bjs/pubalp@.htm#P. Accessed October 15, 2004.
34. Beck AJ, Maruschak LM. Hepatitis testing and treatment in state prisons. Bur Justice Stat Bull. 2004; NCJ 199173C. Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/httsp.pdf. Accessed October 30, 2004.
35. Loney P.L., Chambers L.W., Bennett K.J., Roberts J.G., and Stratford P.W. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 19 (1998) 170-176
36. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283 (2000) 2008-2012
37. Harzke A.J. Hepatitis B and C infections in U.S. Incarcerated Populations: Prevalence and Related Mortality [Dr. P.H. dissertation] (2007), University of Texas School of Public Health, Houston (TX)
38. Statistics/Data Analysis, version 8.2 (1984-2003), StataCorp, College Station (TX)
39. Brown L.D., Cai T.T., and Das Gupta A. Interval estimation for a binomial proportion. Stat Sci 16 (2001) 101-133
40. Lipsey M.W., and Wilson D.B. Practical meta-analysis (2001), Sage Publications, Thousand Oaks (CA)
41. Deeks J.J., Altman D.G., and Bradburn M.J. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M., Smith G.D., and Altman D.G. (Eds). Systematic reviews in health care: meta-analysis in context (2001), BMJ Publishing Group, London 285-312
42. Greenland S. Meta-analysis. In: Rothman K.J., and Greenland S. (Eds). Modern epidemiology. 2nd ed (1998), Lippincott Williams & Wilkins, Philadelphia 643-673
43. Benjamin D.K., Poole C., Steinbach W.J., Rowen J.L., and Walsh T.J. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 112 (2003) 634-640
44. Thompson S.G. Why and how sources of heterogeneity should be investigated. In: Egger M., Smith G.D., and Altman D.G. (Eds). Systematic reviews in health care: meta-analysis in context (2001), BMJ Publishing Group, London 157-175
45. Hamilton L.C. Statistics with Stata: Updated for Version 8. Belmont (CA): Brooks/Cole-Thomson Learning (2004)